NRXS
Price
$3.02
Change
+$0.27 (+9.82%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
27.15M
59 days until earnings call
TNGX
Price
$8.53
Change
+$0.56 (+7.03%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
886.74M
40 days until earnings call
Interact to see
Advertisement

NRXS vs TNGX

Header iconNRXS vs TNGX Comparison
Open Charts NRXS vs TNGXBanner chart's image
Neuraxis
Price$3.02
Change+$0.27 (+9.82%)
Volume$100
Capitalization27.15M
Tango Therapeutics
Price$8.53
Change+$0.56 (+7.03%)
Volume$80.38K
Capitalization886.74M
NRXS vs TNGX Comparison Chart in %
Loading...
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NRXS vs. TNGX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRXS is a Buy and TNGX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (NRXS: $3.02 vs. TNGX: $8.53)
Brand notoriety: NRXS and TNGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRXS: 97% vs. TNGX: 69%
Market capitalization -- NRXS: $27.15M vs. TNGX: $886.74M
NRXS [@Biotechnology] is valued at $27.15M. TNGX’s [@Biotechnology] market capitalization is $886.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRXS’s FA Score shows that 0 FA rating(s) are green whileTNGX’s FA Score has 0 green FA rating(s).

  • NRXS’s FA Score: 0 green, 5 red.
  • TNGX’s FA Score: 0 green, 5 red.
According to our system of comparison, NRXS is a better buy in the long-term than TNGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRXS’s TA Score shows that 6 TA indicator(s) are bullish while TNGX’s TA Score has 4 bullish TA indicator(s).

  • NRXS’s TA Score: 6 bullish, 3 bearish.
  • TNGX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NRXS is a better buy in the short-term than TNGX.

Price Growth

NRXS (@Biotechnology) experienced а +18.72% price change this week, while TNGX (@Biotechnology) price change was +12.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

NRXS is expected to report earnings on Nov 24, 2025.

TNGX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNGX($887M) has a higher market cap than NRXS($27.2M). TNGX YTD gains are higher at: 176.052 vs. NRXS (28.319). NRXS has higher annual earnings (EBITDA): -7.01M vs. TNGX (-154.8M). TNGX has more cash in the bank: 181M vs. NRXS (5.99M). NRXS has less debt than TNGX: NRXS (410K) vs TNGX (35M). TNGX has higher revenues than NRXS: TNGX (24.3M) vs NRXS (3.22M).
NRXSTNGXNRXS / TNGX
Capitalization27.2M887M3%
EBITDA-7.01M-154.8M5%
Gain YTD28.319176.05216%
P/E RatioN/AN/A-
Revenue3.22M24.3M13%
Total Cash5.99M181M3%
Total Debt410K35M1%
TECHNICAL ANALYSIS
Technical Analysis
NRXSTNGX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDNNX79.84N/A
N/A
Janus Henderson Growth And Income N
PBSRX16.38N/A
N/A
Polen US Small Company Growth Investor
SSTFX11.36N/A
N/A
Virtus KAR Capital Growth C
BIEAX26.59N/A
N/A
Brandes International Equity A
JABGX12.25N/A
N/A
JHancock Real Estate Securities I

NRXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXS has been loosely correlated with CVM. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if NRXS jumps, then CVM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
+9.65%
CVM - NRXS
59%
Loosely correlated
+5.16%
PTIX - NRXS
45%
Loosely correlated
+1.42%
ARMP - NRXS
38%
Loosely correlated
-0.34%
TNGX - NRXS
29%
Poorly correlated
+7.03%
BTAI - NRXS
27%
Poorly correlated
-3.72%
More

TNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNGX has been loosely correlated with IMTX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TNGX jumps, then IMTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNGX
1D Price
Change %
TNGX100%
+7.03%
IMTX - TNGX
39%
Loosely correlated
+9.29%
FDMT - TNGX
39%
Loosely correlated
-0.36%
LEGN - TNGX
36%
Loosely correlated
+1.71%
BDTX - TNGX
36%
Loosely correlated
+9.16%
FATE - TNGX
35%
Loosely correlated
+2.39%
More